Blogs about ACAD - Stockpickr! Your Source for Stock Ideas

Blogs about ACAD

Blogs	Description	Date Updated
Wednesday's Upgrades and Downgrades	UpgradesInter Parfums (IPAR)- Caris & Company Above Average » Buy Schnitzer Steel (SCHN)- Longbow Neutral » Buy Genesis Energy, L.P. (GEL)- Morgan Keegan Mkt Perform » Outperform UPS (UPS)- Stifel Nicolaus Hold » Buy United Dominion (UDR)- Stifel Nicolaus Hold » Buy Equity Res (EQR)- Stifel Nicolaus Hold » Buy UnionBanCal (UB)- BMO Capital Markets Underperform » Market Perform Bankrate (RATE)- RBC Capital Mkts Sector Perform » Outperform Medivation (MDVN...	July 09, 2008
Wednesday's Upgrades and downgrades	UPGRADESWyeth (WYE)- Leerink Swann Mkt Perform » Outperform Worthington (WOR)- Longbow Neutral » Buy Weingarten Realty (WRI)- Stifel Nicolaus Hold » Buy Ramco-Gershenson (RPT)- Stifel Nicolaus Hold » Buy Pennsylvania R.E.I.T. (PEI)- Stifel Nicolaus Hold » Buy National Retail Properties (NNN)- Stifel Nicolaus Hold » Buy Capital Lease Funding (LSE)- Stifel Nicolaus Hold » Buy Kite Realty (KRG)- Stifel Nicolaus Hold » Buy Glimcher Realty (GRT)- Stifel Nico...	June 18, 2008
Analyst downgrades: CTXS, ACAD and TRGL	Filed under: Analyst upgrades and downgradesMOST NOTEWORTHY: Citrix Systems, Acadia Pharmaceuticals and Toreador Resources were today's noteworthy downgrades: Friedman Billings downgraded Citrix Systems (NASDAQ: CTXS) to Market Perform from Outperform citing the departure of key executive John Burris, head of CTXS's sales and services organization. The firm lowered the target to $37 from $43. Banc of America cut Acadia Pharmaceuticals (NASDAQ: ACAD) to Sell from Buy following news ...	June 17, 2008
VOLUME SURGE: ACADIA Goes To The Swamp (ACAD)	ACADIA Pharmaceuticals (NASDAQ: ACAD) is already having a horrible day and is likely going to crisis-mode. Shares are being more than cut in half and we have already past 150,000 shares even though it is only 8:20 AM EST. Shares were halted after closing at $8.49 on Friday, but have re-opened down under $4.00 in early-bird trading. The company’ phase IIb schizophrenia is a bust on all accounts. 52-week trading range was $7.63 to $17.33. Average Volume: 220,000 OPTIONS: YES...	June 16, 2008
Biotech Busine$$ Daily (ACAD, AMLN, CVTX, HALO, KOSN, MCU, NVAX, POZN, REGN, SIRT)	If you thought biotech news was getting quiet going into earnings season, think again. Acadia Pharmaceuticals Inc. (ACAD) presents Phase II data on... [[ This is a content summary only. Visit my website for full links, other content, and more! ]] ...	April 16, 2008
Jim Cramer's Lightning Round	BullishExelon (EXC), Duke Energy (DUK) and ConAgra Foods (CAG).BearishCrocs (CROX), Countrywide Financial (CFC), Acadia Pharmaceuticals (ACAD), Zoltek (ZOLT), IAC/InterActiveCorp (IACI), Aircastle (AYR) and PNM Resources (PNM). ...	March 27, 2008
Jim Cramer's Lightning Round & Sudden Death	BullishEMC Corporation (EMC), Wal-Mart Stores Inc. (WMT), Cisco Systems Inc. (CSCO), Acadia Pharmaceuticals Inc. (ACAD), Omniture Inc. (OMTR), TOP Tankers Inc. (TOPT), Frontline Ltd. (FRO), Advanced Micro Devices Inc. (AMD), Cal Dive International Inc. (DVR), Hercules Offshore Inc. (HERO), Transocean Inc. (RIG), Global Santa Fe Corporation (GSF), Schlumberger Limited (SLB), Southern Copper Corporation (PCU) and Freeport McMoRan Copper & Gold Inc. (FCX). BearishTarget Corporation...	July 12, 2007
Pre-Market Analyst Calls (July 10, 2007)	ACAD started as Outperform at FBR.ALC started as Outperform at RBC.ARUN started as Buy at Jefferies.ATVI started as Buy at First Albany.AZ raised to Buy at UBS.CHA cut to Hold at Deutsche Bank.DRIV raised to Outperform at RBC.DTV raised to Buy at Citigroup.EMC started as Mkt Perform at BMO Capital Markets.F raised to Overweight at JPMorgan.FOLD started as Overweight at JPMorgan.FORM cut to Underweight at JPMorgan.FVE started as Sector Perform at RBC.GGG cut to Sector Perform at CIBC.GM raised to...	July 10, 2007
Acadia Pharmaceuticals Inc. CEO Interview	Acadia Pharmaceuticals Inc. (ACAD) CEO Dr. Uli Hacksell was on Mad Money tonight and he made some bullish comments on his companies progress in its schizophrenia treatments. Acadia has been busy working on two schizophrenia programs, one of which the advanced program recently completed a phase II study, Dr. Hacksell said. Acadia is actively searching for an alliance with a partner that will help take the program through phase III. Jim thinks that ACAD will find a partner and he backed his $14 b...	June 21, 2007
Cramer Speculates in CV Therapeutics (CVTX)	On tonight's Mad Money on CNBC, Jim Cramer had his normal 'Speculation Friday' and talked CV Therapeutics (CVTX) for a speculative biotech in with Acadia (ACAD) and Nastech (NSTK). Cramer said CVTX is a huge battle ground stock that makes small molecule drugs. Last month it had 36% of the float short, but he thinks the bearish case just doesn't hold up. Cramer thinks the stock could explode into the $20's because of earnings, or it could get acquired and go there. Its Ran...	June 15, 2007

Enter search text here: